Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SHIRE LLC v. PAR PHARMACEUTICAL, INC. et al
Case Number:
1:15-cv-01454
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 24, 2015
Shire Blocks Par From Selling Adderall Generic
A New Jersey federal judge signed off Tuesday on a permanent injunction barring Par Pharmaceutical Inc. from selling a generic version of Shire LLC's attention deficit hyperactivity disorder medication Adderall XR.
-
July 27, 2015
Shire Allowed Access To Confidential Info In Adderall Row
Amerigen Pharmaceuticals Inc. has to let Shire LLC look through its confidential information, namely its abbreviated new drug application, to figure out if it infringed Shire's patent for Adderall XR, a New Jersey magistrate judge ruled Friday.
-
February 26, 2015
Shire Hits Par With Patent Suit Over Generic Adderall
Shire LLC slapped rival Par Pharmaceutical Inc. on Thursday with a patent infringement suit in New Jersey federal court over Par's application to market a generic version of Shire's attention deficit hyperactivity disorder medication Adderall XR.